The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO GI 2021 | Next-generation sequencing and emerging targets

Name: Next-generation sequencing and emerging targets
Uploaded: 2021-01-20T00:00:00Z
Duration: 4 min 29 s
Description: Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, discusses the use of next-generation sequencing and emerging targets in patients with gastrointestinal (GI) cancer and highlights key actionable mutations present in GI malignancies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Kohei Shitara • 20 Jan 2021

ASCO GI 2021

Gastrointestinal Cancer

Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, discusses the use of next-generation sequencing and emerging targets in patients with gastrointestinal (GI) cancer and highlights key actionable mutations present in GI malignancies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).